You're reading the free version. Trader adds the live tape and alerts.
Start tracking
GRCE Buy Disclosure
Opaleye Management Inc. · SEC Form 4 · Filed Oct 13, 2026
Buy
Calculated transaction value
$4.19K
Opaleye Management Inc. 10% owner
GRCE
Grace Therapeutics
GRCE
Transaction date
Oct 8, 2026
Public filing date
Oct 13, 2026
Filing lag
Filed 5 days later
GRCE daily price context
Close on/before transaction
$2.04
Oct 8, 2026
First close after public filing
$1.89
Oct 14, 2026
30-day return after filing
-3.7%
Through Nov 12, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock, par value $0.0001 per share
- Quantity / price
- 2,077 shares @ $2.02
- SEC ownership
- Indirect
- Transaction code
- P
- Form
- 4
- Filing identifier
- 0001493152-26-046899
Filing cohort
Transactions in this filing
Showing 3 of 3
Trades
3
Issuers
1
Estimated value
$29.68K
Buys / sales
3 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Grace Therapeutics, Inc. GRCE | Buy | Oct 12, 2026 | $14.57K |
| Grace Therapeutics, Inc. GRCE | Buy | Oct 9, 2026 | $10.92K |
| Grace Therapeutics, Inc. GRCE Current | Buy | Oct 8, 2026 | $4.19K |